Dana-Farber Cancer Institute

Dana-Farber Cancer Institute is an independent cancer treatment and research institute in Boston and a principal teaching affiliate of Harvard Medical School. As a founding member of the Dana-Farber/Harvard Cancer Center, an NCI-designated Comprehensive Cancer Center, it unites laboratory discovery with hospital care to accelerate translation and sustains an extensive clinical-trials portfolio. Industry partners engage through sponsored research, collaboration frameworks, and access to materials and data, coordinated by the Belfer Office for Dana-Farber Innovations. Research is supported primarily by NIH, especially NCI, alongside competitive foundation and industry funding. A dedicated commercialization team advances IP, licensing, and alliances from discovery through early development.